Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.85 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 6/20 | 0.58 |
| ▸ | PPARD | Q03181 | 6/20 | 0.58 |
| ▸ | PPARA | Q07869 | 6/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31524795 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL31524916 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL31524960 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL1884346 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL1881604 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL335502 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL16230497 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL1881322 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL31524686 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG | |
| SCHEMBL31524893 | 1.00 | FFAR4 (0.85) | FFAR4FFAR1ALDH1A1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | AGAIN BIO APS (DK) | 2026-03-05 | — | — | US | disclosed |
| EP-4150103-B1 | METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS | U WINDMOELLER INNOVATION GMBH & CO KG (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-20250019731-A1 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | AGAIN BIO APS (DK) | 2025-01-16 | — | — | US | disclosed |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | OXFORD FINANCE LLC | 2024-09-19 | — | — | US | disclosed |
| CN-118460487-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118374462-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-105378486-B | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11981952-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| US-20210189439-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | GENOMATICA, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| CN-103343049-B | Fragrance composition | KAO CORP | 2014-05-07 | — | — | CN | disclosed |
| EP-2376467-B1 | FRAGRANCE COMPOSITION | KAO CORP (JP) | 2014-03-12 | — | — | EP | disclosed |
| CN-103343049-A | Fragrance composition | KAO CORP | 2013-10-09 | — | — | CN | disclosed |
| US-8338361-B2 | Fragrance composition | KAO CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| CN-102264718-A | Perfume composition | — | 2011-11-30 | — | — | CN | disclosed |
| US-20110269664-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-2376467-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010082684-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2010-07-22 | — | — | WO | disclosed |
| EP-0711746-A1 | Process for preparing hydroxycarboxylic acids | UNILEVER PLC (GB) | 1996-05-15 | — | — | EP | disclosed |
| US-5502226-A | SELECTIVE REDUCTION OF DIKETONE TO KETO ACIDS USING HYDROGEN IN THE PRESENCE OF BASE | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1996-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | FASN, FFAR1, FFAR3 | FFAR4 18/4885FFAR1 2/4885ALDH1A1 398/4885 |
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | FFAR4 95/4885FFAR1 112/4885ALDH1A1 327/4885 |
| US-20110269664-A1 | FRAGRANCE COMPOSITION | MSI2, MUS81, EMC1 | FFAR4 1681/4885FFAR1 966/4885ALDH1A1 1183/4885 |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | DGAT2, DGAT1, FASN | FFAR4 76/4885FFAR1 31/4885ALDH1A1 1172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.